Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Alkyl Amines Chemicals Limited manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. The company offers aliphatic amine products, such as methylamines, ethylamines, isopropylamines, n-propylamines, n-butylamines, ethylhexylamines, furfurylamines, and cyclohexylamines; and amine derivatives, including dimethylamine hydrochloride, diethylamine hydrochloride, triethylamine hydrochloride, 3-ethoxy propylamine, 3-(methylaminopropyl) amine, dimethylaminopropylamine, 3-(2-ethylhexyloxy) propylamine, n-methylbenzylamine, diisopropyl ethylamine, diethylhydroxylamine, diethyl toluamide, and diethylphenyl acetamide. It also provides specialty chemicals, such as acetonitrile; 1,8-diazabicyclo[5.4.0]undec-7-ene; diethylketone/3-pentanone; alchan 100; alchan 300; 2-aminoethoxy ethanol; 2-ethoxy ethylamine; dimethylpropyleneurea; tetramethyl ethylenediamine; monomethylamine; and tempo, free radical. The company serves pharmaceutical, agrochemical, water treatment, rubber chemical, and other industries. Alkyl Amines Chemicals Limited was incorporated in 1979 and is headquartered in Navi Mumbai, India.

Revenue projections:

Revenue projections for ALKYLAMINE
Revenue projections for ALKYLAMINE

Revenues for ALKYLAMINE are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 0.00000
forwardPE 32.21385
debtToEquity 0.39400
earningsGrowth 0.01000
revenueGrowth 0.01500
grossMargins 0.45111
operatingMargins 0.14470
trailingEps 35.58000
forwardEps 49.10000

ALKYLAMINE's negative gross and operating margins indicate that the company is unable to generate profit from its core business activities. This suggests financial strain and could be a sign of deeper cost management issues.
With a forward EPS greater than its trailing EPS, ALKYLAMINE is forecasted to be more profitable this year than last. This growth expectation reflects confidence in the company's earnings potential and suggests an improving financial trajectory for the year ahead.

Price projections:

Price projections for ALKYLAMINE
Price projections for ALKYLAMINE

The current valuation of ALKYLAMINE against its projections does not reveal significant risks or opportunities. This neutral assessment implies a stable market, where investors may prefer to maintain their positions until future trends become clearer.

Insider Transactions:

Insider Transactions for ALKYLAMINE
Insider Transactions for ALKYLAMINE


9 ALKYLAMINE sales were executed, with market price at 1882.272216796875.7 separate purchases of ALKYLAMINE stock were made, while market price was at 1701.0499965122767 per share.More buys than sells near the current price levels of ALKYLAMINE might signal a favorable outlook for the stock. Investors seem to be showing confidence by purchasing more, potentially expecting positive future performance.

Recommendation changes over time:

Recommendations trend for ALKYLAMINE
Recommendations trend for ALKYLAMINE


Analysts have recently developed a sell bias for ALKYLAMINE, suggesting caution when making investment decisions. Investors are advised to rely on a broad range of market indicators rather than solely on this bias to ensure a more comprehensive understanding of the stock's potential before taking action.